skip to main content
Idioma:
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012
Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012
Material Type:
Artigo 		Adicionar ao Meu Espaço

Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012

Sacks, Leonard V ; Shamsuddin, Hala H ; Yasinskaya, Yuliya I ; Bouri, Khaled ; Lanthier, Michael L ; Sherman, Rachel E

JAMA : the journal of the American Medical Association, 2014-01, Vol.311 (4), p.378-384 [Periódico revisado por pares]

Chicago, IL: American Medical Association

Texto completo disponível

Citações Citado por
2
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Jayk Bernal, Angélica ; Gomes da Silva, Monica M ; Musungaie, Dany B ; Kovalchuk, Evgeniy ; Gonzalez, Antonio ; Delos Reyes, Virginia ; Martín-Quirós, Alejandro ; Caraco, Yoseph ; Williams-Diaz, Angela ; Brown, Michelle L ; Du, Jiejun ; Pedley, Alison ; Assaid, Christopher ; Strizki, Julie ; Grobler, Jay A ; Shamsuddin, Hala H ; Tipping, Robert ; Wan, Hong ; Paschke, Amanda ; Butterton, Joan R ; Johnson, Matthew G ; De Anda, Carisa

The New England journal of medicine, 2022-02, Vol.386 (6), p.509-520 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial

Johnson, Matthew G. ; Strizki, Julie M. ; Brown, Michelle L. ; Wan, Hong ; Shamsuddin, Hala H. ; Ramgopal, Moti ; Florescu, Diana F. ; Delobel, Pierre ; Khaertynova, Ilsiyar ; Flores, José F. ; Fouche, Leon F. ; Chang, Shan-Chwen ; Williams-Diaz, Angela ; Du, Jiejun ; Grobler, Jay A. ; Paschke, Amanda ; De Anda, Carisa

Infection, 2023-10, Vol.51 (5), p.1273-1284 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
4
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Jayk Bernal, Angélica ; Gomes da Silva, Monica M. ; Musungaie, Dany B. ; Kovalchuk, Evgeniy ; Gonzalez, Antonio ; Delos Reyes, Virginia ; Martín-Quirós, Alejandro ; Caraco, Yoseph ; Williams-Diaz, Angela ; Brown, Michelle L. ; Du, Jiejun ; Pedley, Alison ; Assaid, Christopher ; Strizki, Julie ; Grobler, Jay A. ; Shamsuddin, Hala H. ; Tipping, Robert ; Wan, Hong ; Paschke, Amanda ; Butterton, Joan R. ; Johnson, Matthew G. ; De Anda, Carisa

The New England journal of medicine, 2022-02, Vol.386 (6), p.509-520 [Periódico revisado por pares]

Massachusetts Medical Society

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.